Back to BetterHealthGuy

EP235: Inside CIRS Lab and the Evolving Science of Biotoxin Illness - Christian Navarro-Torres, PhD

BetterHealthGuyJune 15, 20262h 7m
Topics62
Podcast Introduction0:01Episode 235 Introduction0:35Personal Health Journey as Catalyst2:33Background Before Illness4:00Onset of Symptoms in 20196:012020 Symptom Flare and COVID Timing8:042021 Functional Medicine Work and Charcoal Trial9:31SIRS Diagnosis and Introduction to Shoemaker Protocol11:00Treatment Progression and Limitations12:33Self-Experimentation Period14:31Gratitude for Foundational Work16:02Sensitivity and Microdosing Approach17:01Environmental Management During Sensitivity20:39Nervous System Regulation and Trauma Considerations22:04Suspected Co-Infections and Colonization24:03Trauma and Its Role in CIRS Severity25:01HLA-DR Types and CIRS Predisposition26:35Actinobacteria as a Late-Stage Driver29:05Mycotoxin Detoxification and Inflammation31:34GENIE Transcriptomics Testing34:01Traditional Biotoxin Markers: C4a, TGF-beta-1, MSH38:02NeuroQuant Ordering and Technical Process41:31NeuroQuant Patterns in CIRS45:30NeuroQuant Analysis and Brain Pattern Recognition49:38NeuroQuant Retesting Intervals and Treatment Approaches51:04Lipid Interventions and Choline Sources53:34Prodrome Scan and Testing Integration55:31Testing Preferences and Limitations57:01Environmental Assessment and Remediation58:06Immune System in CIRS1:01:32Autoimmunity and Microbial Burden Connections1:05:01Research Paper on MARCoNS and MSH1:08:30Need for Published Research on Staph and Related Organisms1:15:25Expanding Beyond Marcons with Broader Sinus Testing1:16:32Actinobacteria Findings in Sinus Biome1:17:30Fungal and Actinobacteria Correlations1:19:37Actinobacteria Causation Percentages and Timing1:20:50Addressing Actinobacteria as Prerequisite or Primary Focus1:21:33Metabolic and Zombification Symptoms1:22:30Immune Dysregulation Profile1:23:34pH and Ecosystem Considerations1:24:32Blood vs. Mucosal pH Patterns1:26:00Horopito as Intervention Tool1:27:01Endotoxins Role and Sources1:29:30Natural Binders and Charge Properties1:33:00Cholecevalam Preference and Clinical Movement1:36:00Environmental vs. Endogenous Actinobacteria1:36:30Vector-Borne Infections and Testing Limitations1:38:31Microbial Burdens Beyond Mold and Mycotoxins1:41:12Bartonella in the CIRS Population1:42:02Chronic Viral Contributors1:43:32Parasitic Infections in CIRS and Chronic Illness1:45:31Parasite Treatment Approaches1:48:01Gut Issues and Interconnected Systems1:49:00Microbiome Testing Tools1:50:30Fungal Colonization and Antifungal Use1:51:32Post-Pandemic Observations and COVID1:54:31Coagulation Issues in CIRS1:57:01Mast Cell Activation and Histamine Issues1:59:31Expanding Beyond the 12-Step Protocol2:01:31Prioritizing Sinus Treatment2:03:01Daily Health Practices and Reintegration2:04:01
In a Nutshell

Dr. Christian Navarro-Torres, a CIRS patient and neuroscientist, details how his severe biotoxin illness progressed from mold exposure to high actinobacteria burden, Bartonella, Babesia, and parasitic colonization, requiring interventions beyond the standard Shoemaker protocol. Key findings include NeuroQuant showing brain atrophy patterns tied to actinobacteria and vascular stress, sinus biome testing revealing dominant actinobacteria like C. acnes correlating with low MSH and metabolic failure, and VIP plus Prodrome Glia as the most effective interventions for restoring brain volumes. Treatment success depends on prioritizing environmental removal, sinus actinobacteria clearance, and addressing endogenous infections and parasites in proper sequence, with HLA-DR and early trauma identified as severity predictors rather than direct causes.

AI-Generated Notes

These notes were generated by AI and may contain inaccuracies.

The Better Health Guy podcast explores complex chronic conditions and ways to build resilience, improve vitality, and achieve better health. Content is for informational purposes only and not intended to diagnose, treat, or cure any illness. Nothing discussed should be considered medical advice.

Episode 235 features Dr. Christian Navarro-Torres, a cognitive neuroscientist with formal training in cognitive psychology, neuroscience, language science, and applied data analysis. He earned his PhD in language science from the University of California, Irvine, a master's in cognitive psychology at Penn State, and a bachelor's in philosophy from the University of Puerto Rico. His research career included postdoctoral fellowships at Princeton University and Georgetown University, focusing on experience-dependent neuroplasticity and clinical assessment in patients with brain damage affecting language and cognition.

Dr. Navarro-Torres is co-founder of SIRS Lab, scientific director of the SIRS Research Foundation, and a research consultant for the Einstein Mission investigating erythromelalgia and SIRS. His recent scientific work extends into environmental health and immune dysregulation, including publications and presentations on biotoxin illness, its multi-system and multi-symptom pathology, and treatment outcomes, with particular interest in how SIRS-related brain changes may contribute to neurodegenerative processes.

Sign in to read the full notes

Get access to AI-generated notes, topic timestamps, and more.